HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prothrombin conversion intermediate effectively neutralizes toxic levels of hirudin.

Abstract
Meizothrombin, the stable intermediate product of ecarin-induced prothrombin conversion, was investigated for its ability to bind hirudin in blood. After in vitro pre-incubation of rat plasma with ecarin, the prolongation of the thrombin time caused by hirudin was reduced. The extent of hirudin neutralization was found to be dependent on the duration of incubation with ecarin. In vivo, after bilateral nephrectomy in Wistar rats and following administration of hirudin at a dose of 1 or 5 mg/kg, the blood level of hirudin remained constant after 2 h. After infusion of ecarin following hirudin administration, the hirudin blood level dropped sharply, reaching significantly reduced values, and bleeding stopped. Platelet count and fibrinogen level in plasma remained unchanged in the experiments using ecarin-induced prothrombin conversion intermediate generation. It is concluded that meizothrombin, a naturally occurring prothrombin conversion intermediate, provides an effective agent to neutralize toxic blood levels of hirudin.
AuthorsG Nowak, E Bucha
JournalThrombosis research (Thromb Res) Vol. 80 Issue 4 Pg. 317-25 (Nov 15 1995) ISSN: 0049-3848 [Print] United States
PMID8585044 (Publication Type: Journal Article)
Chemical References
  • Antithrombins
  • Enzyme Precursors
  • Fibrinolytic Agents
  • Hirudins
  • Prothrombin
  • Endopeptidases
  • Thrombin
  • meizothrombin
  • ecarin
Topics
  • Animals
  • Antithrombins (drug effects)
  • Blood Coagulation (drug effects, physiology)
  • Endopeptidases (pharmacology)
  • Enzyme Precursors (pharmacology)
  • Female
  • Fibrinolytic Agents (pharmacology)
  • Hirudins (antagonists & inhibitors)
  • Male
  • Nephrectomy
  • Prothrombin (drug effects, metabolism)
  • Rats
  • Rats, Wistar
  • Thrombin (pharmacology)
  • Thrombin Time

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: